Antiphospholipid antibodies during acute COVID-19 are not associated with long COVID: findings from a retrospective cohort study
IntroductionLong COVID is a public health issue with complex pathophysiology, potentially involving immunoinflammatory and prothrombotic mechanisms. Antiphospholipid antibodies (aPL) have been observed in acute COVID-19 and speculated to contribute to …